Governments, researchers, and industry partners around the world have mobilized to develop diagnostics, therapeutics, and vaccines for COVID-19. The development of new recommendations and practices continue to be deployed to slow the spread of COVID-19. The burden of drug-resistant infections could surpass COVID-19. Drugs like antibiotics are a vital tool for modern medicine, used to prevent and treat infections. As drug-resistant infections are becoming more common, modern medicine as we know it is at risk and much like COVID-19, it has the potential to overwhelm our healthcare structure.

What changes are needed to reshape strategies for combatting antimicrobial resistance globally?

Thursday 19 November | 9am EST

This series is delivered by the Antimicrobial Resistance Fighter Coalition. 

Speakers:

• Jeremy Knox, Wellcome
• James Anderson, GSK
• Michael Craig, CDC
• Nana Kuo, United Nations
• Mirfin Mphundu, ReAct Africa
• Kathy Talkington, The Pew Charitable Trust

Find out more and register for the webinar